One question has relentlessly followed ChatGPT in its trajectory to superstar status in the field of artificial intelligence: Has it met the Turing test of generating output indistinguishable from human response?
ChatGPT may be smart, quick and impressive. It does a good job at exhibiting apparent intelligence. It sounds humanlike in conversations with people and can even display humor, emulate the phraseology of teenagers, and pass exams for law school.
But on occasion, it has been found to serve up totally false information. It hallucinates. It does not reflect on its own output.
Cameron Jones, who specializes in language, semantics and machine learning, and Benjamin Bergen, professor of cognitive science, drew upon the work of Alan Turing, who 70 years ago devised a process to determine whether a machine could reach a point of intelligence and conversational prowess at which it could fool someone into thinking it was human.
Their report titled “Does GPT-4 Pass the Turing Test?” is available on the arXiv preprint server.
They rounded up 650 participants and generated 1,400 “games” in which brief conversations were conducted between participants and either another human or a GPT model. Participants were asked to determine who they were conversing with.
The researchers found that GPT-4 models fooled participants 41% of the time, while GPT-3.5 fooled them only 5% to 14% of the time. Interestingly, humans succeeded in convincing participants they were not machines in only 63% of the trials.
The researchers concluded, “We do not find evidence that GPT-4 passes the Turing Test.”
They noted, however, that the Turing test still retains value as a measure of the effectiveness of machine dialogue.
“The test has ongoing relevance as a framework to measure fluent social interaction and deception, and for understanding human strategies to adapt to these devices,” they said.
They warned that in many instances, chatbots can still communicate convincingly enough to fool users in many instances.
“A success rate of 41% suggests that deception by AI models may already be likely, especially in contexts where human interlocutors are less alert to the possibility they are not speaking to a human,” they said. “AI models that can robustly impersonate people could have could have widespread social and economic consequences.”
The researchers observed that participants making correct identifications focused on several factors.
Models that were too formal or too informal raised red flags for participants. If they were too wordy or too brief, if their grammar or use of punctuation was exceptionally good or “unconvincingly” bad, their usage became key factors in determining whether participants were dealing with humans or machines.
Test takers also were sensitive to generic-sounding responses.
“LLMs learn to produce highly likely completions and are fine-tuned to avoid controversial opinions. These processes might encourage generic responses that are typical overall, but lack the idiosyncrasy typical of an individual: a sort of ecological fallacy,” the researchers said.
The researchers have suggested that it will be important to track AI models as they gain more fluidity and absorb more humanlike quirks in conversation.
“It will become increasingly important to identify factors that lead to deception and strategies to mitigate it,” they said.
News
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]
A Deadly Ebola-Like Virus Is Spreading. Are We Ready?
BU virologist Nancy Sullivan says the Bundibugyo outbreak in the Democratic Republic of the Congo underscores the need for broader outbreak preparedness. The death of a nurse marked the moment health officials recognized that [...]
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]















